These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1421414)

  • 1. Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease.
    Dietrich PY; Caignard A; Diu A; Genevee C; Pico JL; Henry-Amar M; Bosq J; Angevin E; Triebel F; Hercend T
    Blood; 1992 Nov; 80(9):2419-24. PubMed ID: 1421414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease.
    Jiang YZ; Mavroudis DA; Dermime S; Molldrem J; Hensel NF; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(9):899-903. PubMed ID: 9156263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo T-cell clonal amplification at time of acute graft-versus-host disease.
    Dietrich PY; Caignard A; Lim A; Chung V; Pico JL; Pannetier C; Kourilsky P; Hercend T; Even J; Triebel F
    Blood; 1994 Oct; 84(8):2815-20. PubMed ID: 7919391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
    Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
    Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.
    Faber LM; van Luxemburg-Heijs SA; Veenhof WF; Willemze R; Falkenburg JH
    Blood; 1995 Oct; 86(7):2821-8. PubMed ID: 7670118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of T-cell receptor repertoire in bone marrow transplant recipients: evidence for oligoclonal T-cell expansion in graft-versus-host disease lesions.
    Liu X; Chesnokova V; Forman SJ; Diamond DJ
    Blood; 1996 Apr; 87(7):3032-44. PubMed ID: 8639927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease.
    Gaschet J; Treviño MA; Cherel M; Vivien R; Garcia-Sahuquillo A; Hallet MM; Bonneville M; Harrousseau JL; Bragado R; Milpied N; Vié H
    Blood; 1996 Mar; 87(6):2345-53. PubMed ID: 8630397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.
    Hessner MJ; Endean DJ; Casper JT; Horowitz MM; Keever-Taylor CA; Roth M; Flomenberg N; Drobyski WR
    Blood; 1995 Nov; 86(10):3987-96. PubMed ID: 7579370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
    Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
    Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro T-cell receptor V beta repertoire analysis may identify which T-cell V beta families mediate graft-versus-leukaemia and graft-versus-host responses after human leucocyte antigen-matched sibling stem cell transplantation.
    Epperson DE; Margolis DA; McOlash L; Janczak T; Barrett AJ
    Br J Haematol; 2001 Jul; 114(1):57-62. PubMed ID: 11472345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different T-cell receptor repertoires between lesions and peripheral blood in acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Kubo K; Yamanaka K; Kiyoi H; Fukutani H; Ito M; Hayakawa R; Ohno R; Naoe T
    Blood; 1996 Apr; 87(7):3019-26. PubMed ID: 8639925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation.
    van der Straaten HM; Fijnheer R; Dekker AW; Nieuwenhuis HK; Verdonck LF
    Br J Haematol; 2001 Jul; 114(1):31-5. PubMed ID: 11472341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.
    Niederwieser D; Grassegger A; Auböck J; Herold M; Nachbaur D; Rosenmayr A; Gächter A; Nussbaumer W; Gaggl S; Ritter M
    Blood; 1993 Apr; 81(8):2200-8. PubMed ID: 8471780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire.
    Margolis DA; Casper JT; Segura AD; Janczak T; McOlash L; Fisher B; Miller K; Gorski J
    Biol Blood Marrow Transplant; 2000; 6(4):408-15. PubMed ID: 10917576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.
    Drobyski WR; Ash RC; Casper JT; McAuliffe T; Horowitz MM; Lawton C; Keever C; Baxter-Lowe LA; Camitta B; Garbrecht F
    Blood; 1994 Apr; 83(7):1980-7. PubMed ID: 8142664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers.
    Schilbach K; Schick J; Fluhr H; Marquordt K; Wehrmann M; Schütt BS; Schlegel PG; Niethammer D; Eyrich M
    Transplantation; 2004 Jul; 78(1):31-40. PubMed ID: 15257036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
    Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
    J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
    Drobyski WR; Hessner MJ; Klein JP; Kabler-Babbitt C; Vesole DH; Margolis DA; Keever-Taylor CA
    Blood; 1999 Jul; 94(2):434-41. PubMed ID: 10397710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine receptor gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Hashino S; Higa T; Sakurada K; Asaka M
    Leuk Lymphoma; 1995 Oct; 19(3-4):281-7. PubMed ID: 8535220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.